Poloxamer 188
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Poloxamer 188, covering 2012-03-06 to 2012-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease [Phase 3]